One other VERY important factor I left out:

Does anyone believe George Mason U would make a presentation to the world's leading body of virologists if they didn't have data that is going to blow their socks off?

Is there any rationale for them to make a presentation to say that B is a so-so drug or something less than advertised?

Would GMU be continuing to investigate Brilacidin for an entire YEAR if they had not seen results that are unheard of as to efficacy?

My answer is a strong NO to all the above!!!

Follow the money - GMU is expecting this presentation in July to bring in BIG BUCKS to their bio lab facility and they are going to accomplish it using Brilacidin as their focal study area.

Can't get much more positive than that!!